Anterior Chamber Bleeding After Laser Peripheral Iridotomy | Cardiology | JAMA Ophthalmology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Quigley HA. Number of people with glaucoma worldwide.  Br J Ophthalmol. 1996;80(5):389-3938695555PubMedGoogle ScholarCrossref
2.
He M, Friedman DS, Ge J,  et al.  Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes: the Liwan Eye Study.  Ophthalmology. 2007;114(3):494-50017123610PubMedGoogle ScholarCrossref
3.
Pandav SS, Kaushik S, Jain R, Bansal R, Gupta A. Laser peripheral iridotomy across the spectrum of primary angle closure.  Can J Ophthalmol. 2007;42(2):233-23717392845PubMedGoogle ScholarCrossref
4.
Robin AL, Pollack IP. A comparison of neodymium: YAG and argon laser iridotomies.  Ophthalmology. 1984;91(9):1011-10166387569PubMedGoogle Scholar
5.
Quigley HA. Long-term follow-up of laser iridotomy.  Ophthalmology. 1981;88(3):218-2247231918PubMedGoogle Scholar
6.
Liebmann JM, Ritch R. Laser surgery for angle closure glaucoma.  Semin Ophthalmol. 2002;17(2):84-9115513461PubMedGoogle ScholarCrossref
7.
Del Priore LV, Robin AL, Pollack IP. Neodymium: YAG and argon laser iridotomy. Long-term follow-up in a prospective, randomized clinical trial.  Ophthalmology. 1988;95(9):1207-12113062535PubMedGoogle Scholar
8.
Moster MR, Schwartz LW, Spaeth GL, Wilson RP, McAllister JA, Poryzees EM. Laser iridectomy: a controlled study comparing argon and neodymium:YAG.  Ophthalmology. 1986;93(1):20-243754043PubMedGoogle Scholar
9.
Jiang Y, Chang DS, Foster PJ,  et al.  Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects.  Ophthalmology. 2012;119(2):283-28822036632PubMedGoogle ScholarCrossref
10.
Ho T, Fan R. Sequential argon-YAG laser iridotomies in dark irides.  Br J Ophthalmol. 1992;76(6):329-3311622941PubMedGoogle ScholarCrossref
11.
Krupin T, Stone RA, Cohen BH, Kolker AE, Kass MA. Acute intraocular pressure response to argon laser iridotomy.  Ophthalmology. 1985;92(7):922-9264022578PubMedGoogle Scholar
12.
Davila RG. Anticoagulant therapy in very old patients.  Cardiovasc Hematol Disord Drug Targets. 2011;11(1):24-2921446897PubMedGoogle ScholarCrossref
13.
Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation.  Circ Res. 2007;100(9):1261-127517495233PubMedGoogle ScholarCrossref
14.
Alli O, Smith C, Hoffman M, Amanullah S, Katz P, Amanullah AM. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel.  J Clin Gastroenterol. 2011;45(5):410-41420975574PubMedGoogle ScholarCrossref
15.
Mehta SR, Yusuf S, Peters RJ,  et al; Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.  Lancet. 2001;358(9281):527-53311520521PubMedGoogle ScholarCrossref
16.
Husted S. Benefits and risks with antiplatelet therapy: how great a problem is bleeding?  Eur Heart J Suppl. 2008;10:(suppl 1)  119-124Google ScholarCrossref
17.
Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.  Am J Med. 1993;95(3):315-3288368229PubMedGoogle ScholarCrossref
18.
Douketis JD. Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach.  Hosp Pract (Minneap). 2011;39(4):41-5422056822PubMedGoogle ScholarCrossref
19.
Barequet IS, Sachs D, Shenkman B,  et al.  Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.  J Cataract Refract Surg. 2011;37(8):1434-143821684111PubMedGoogle ScholarCrossref
Clinical Sciences
May 2013

Anterior Chamber Bleeding After Laser Peripheral Iridotomy

Author Affiliations

Author Affiliations: Departments of Ophthalmology, Tel Aviv Medical Center (Drs Golan, Shemesh, and Kurtz) and Sheba Medical Center (Dr Levkovitch-Verbin), Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

JAMA Ophthalmol. 2013;131(5):626-629. doi:10.1001/jamaophthalmol.2013.1642
Abstract

Importance To our knowledge, this is the first study to describe the correlation of anterior chamber bleeding after laser peripheral iridotomy (LPI) and antiplatelet therapy.

Objective To determine the incidence and amount of anterior chamber bleeding after laser peripheral iridotomy in patients whose condition is suggestive of primary angle-closure glaucoma (PACS) who continued their antiplatelet or anticoagulant treatment before undergoing LPI compared with when they discontinued treatment.

Design and Setting A prospective controlled trial.

Patients Patients with suspected bilateral primary angle-closure and no other ocular disease who take antiplatelet or anticoagulant medications regularly (from January 2010-October 2011) were enrolled.

Main Outcome and Measure The incidence of anterior chamber bleeding with and without antiplatelet and anticoagulant therapy.

Results A total of 104 patients (208 eyes) participated in the study. Thirty-six eyes (34.6%) in the treated and untreated arms bled. The amount of bleeding did not differ significantly when the patient was on or off antiplatelet or anticoagulant treatment, nor did the immediate postprocedure mean intraocular pressure (P = .13). The type of antiplatelet or anticoagulant, total laser energy, age, sex, or color of irides were not risk factors for increased bleeding (P = .156 for all parameters).

Conclusions No indication was noted for discontinuing these medications before a high-powered pulsed laser peripheral iridotomy.

×